Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease
Deep remission (DR) is a treatment target in IBD associated with reduced hospitalization and improved outcome. Randomized control trial (RCT) data demonstrates efficacy of anti-TNFα agents in achieving DR; how...